Showing 1 to 12 of 32 results
Blood Test Shows Promise in Early Alzheimer's Diagnosis
A landmark trial in the UK is testing a simple blood test that could replace invasive and costly procedures for diagnosing Alzheimer's disease, affecting millions globally, by measuring p-tau217 protein levels.
Blood Test Shows Promise in Early Alzheimer's Diagnosis
A landmark trial in the UK is testing a simple blood test that could replace invasive and costly procedures for diagnosing Alzheimer's disease, affecting millions globally, by measuring p-tau217 protein levels.
Progress
32% Bias Score
Blood Test Predicts Motor Neurone Disease a Decade Early
A new blood test can identify specific proteins indicating Amyotrophic Lateral Sclerosis (ALS), the most common form of motor neurone disease, up to 10 years before symptom onset, according to a Johns Hopkins University study published in Nature Medicine.
Blood Test Predicts Motor Neurone Disease a Decade Early
A new blood test can identify specific proteins indicating Amyotrophic Lateral Sclerosis (ALS), the most common form of motor neurone disease, up to 10 years before symptom onset, according to a Johns Hopkins University study published in Nature Medicine.
Progress
52% Bias Score
NSW Health Report Finds No Clinical Benefit to PFAS Blood Testing
A NSW Health report concludes that blood tests for PFAS offer no clinical benefit, contradicting US guidance, while a community group is pursuing a class-action lawsuit against the government and Sydney Water over PFAS contamination in the Blue Mountains water supply, with blood test levels two to t...
NSW Health Report Finds No Clinical Benefit to PFAS Blood Testing
A NSW Health report concludes that blood tests for PFAS offer no clinical benefit, contradicting US guidance, while a community group is pursuing a class-action lawsuit against the government and Sydney Water over PFAS contamination in the Blue Mountains water supply, with blood test levels two to t...
Progress
44% Bias Score
Gates Advocates for Alzheimer's Research Following Father's Death
Bill Gates details his experience with his father's battle against Alzheimer's, highlighting the recent FDA approval of a blood-based diagnostic test as a significant breakthrough in early detection and treatment, advocating for increased research funding to combat the disease affecting over seven m...
Gates Advocates for Alzheimer's Research Following Father's Death
Bill Gates details his experience with his father's battle against Alzheimer's, highlighting the recent FDA approval of a blood-based diagnostic test as a significant breakthrough in early detection and treatment, advocating for increased research funding to combat the disease affecting over seven m...
Progress
40% Bias Score
Highly Accurate Blood Test Detects Early-Stage Alzheimer's
A new blood test for Alzheimer's, using amyloid beta 42/40 and p-tau217 proteins, achieves 95% sensitivity and 82% specificity in detecting early symptoms, surpassing invasive tests in convenience and cost-effectiveness, and is FDA-approved.
Highly Accurate Blood Test Detects Early-Stage Alzheimer's
A new blood test for Alzheimer's, using amyloid beta 42/40 and p-tau217 proteins, achieves 95% sensitivity and 82% specificity in detecting early symptoms, surpassing invasive tests in convenience and cost-effectiveness, and is FDA-approved.
Progress
36% Bias Score
PromarkerEso Blood Test Shows High Accuracy in Detecting Oesophageal Cancer
Proteomics International Laboratories' PromarkerEso blood test for oesophageal cancer showed 91.4% accuracy in detecting the cancer and 98.9% accuracy in identifying those without it in a 259-person study, exceeding the accuracy of existing tests and paving the way for commercial release.
PromarkerEso Blood Test Shows High Accuracy in Detecting Oesophageal Cancer
Proteomics International Laboratories' PromarkerEso blood test for oesophageal cancer showed 91.4% accuracy in detecting the cancer and 98.9% accuracy in identifying those without it in a 259-person study, exceeding the accuracy of existing tests and paving the way for commercial release.
Progress
56% Bias Score
£100 Blood Test for Alzheimer's in UK Clinical Trial
A UK clinical trial is testing a £100 blood test for Alzheimer's disease on 1,100 patients to assess its impact on diagnosis speed and treatment decisions, aiming to improve care for the over 500,000 UK residents with the condition.
£100 Blood Test for Alzheimer's in UK Clinical Trial
A UK clinical trial is testing a £100 blood test for Alzheimer's disease on 1,100 patients to assess its impact on diagnosis speed and treatment decisions, aiming to improve care for the over 500,000 UK residents with the condition.
Progress
44% Bias Score
New Blood Test Shows High Accuracy in Detecting Early-Stage Ovarian Cancer
A new blood test for ovarian cancer, developed by AOA Dx and tested on 832 samples, demonstrates 91-93% accuracy in detecting the disease at early stages, using machine learning to analyze blood markers for lipids and proteins, potentially revolutionizing diagnosis and improving patient outcomes.
New Blood Test Shows High Accuracy in Detecting Early-Stage Ovarian Cancer
A new blood test for ovarian cancer, developed by AOA Dx and tested on 832 samples, demonstrates 91-93% accuracy in detecting the disease at early stages, using machine learning to analyze blood markers for lipids and proteins, potentially revolutionizing diagnosis and improving patient outcomes.
Progress
44% Bias Score
Ultrahuman Launches Blood Vision: AI-Powered Blood Test and Smart Ring Health Tracking
Ultrahuman launched its Blood Vision health tracking service in the U.S., combining two blood tests (100+ and 60+ biomarkers) with data from its smart ring to provide AI-driven personalized insights on lifestyle and health, costing $499-$799 annually.
Ultrahuman Launches Blood Vision: AI-Powered Blood Test and Smart Ring Health Tracking
Ultrahuman launched its Blood Vision health tracking service in the U.S., combining two blood tests (100+ and 60+ biomarkers) with data from its smart ring to provide AI-driven personalized insights on lifestyle and health, costing $499-$799 annually.
Progress
44% Bias Score
Liquid Biopsy Speeds Cancer Diagnosis, Improves Patient Outcomes
A 41-year-old woman, Rebeca Proctor, diagnosed with stage 4 lung cancer in January, credits a rapid liquid biopsy which confirmed her cancer's genetic variant ten days sooner than a tissue biopsy, enabling immediate treatment with Brigatinib and significantly improving her quality of life; NHS Engla...
Liquid Biopsy Speeds Cancer Diagnosis, Improves Patient Outcomes
A 41-year-old woman, Rebeca Proctor, diagnosed with stage 4 lung cancer in January, credits a rapid liquid biopsy which confirmed her cancer's genetic variant ten days sooner than a tissue biopsy, enabling immediate treatment with Brigatinib and significantly improving her quality of life; NHS Engla...
Progress
44% Bias Score
Statins Show 39% Reduction in Sepsis Mortality
A study of 12,000 sepsis patients in an Israeli hospital over a decade found that statins reduced the risk of death by 39 percent, with a 14.3 percent death rate within 28 days for statin users versus 23.4 percent for non-users in intensive care.
Statins Show 39% Reduction in Sepsis Mortality
A study of 12,000 sepsis patients in an Israeli hospital over a decade found that statins reduced the risk of death by 39 percent, with a 14.3 percent death rate within 28 days for statin users versus 23.4 percent for non-users in intensive care.
Progress
40% Bias Score
FDA Clears New Blood Test for Alzheimer's Diagnosis
The FDA approved the Lumipulse G Plasma Ratio blood test for Alzheimer's, offering a less invasive and potentially cheaper diagnostic for patients over 55 with cognitive decline; the test achieved 92% accuracy in clinical trials detecting amyloid and tau proteins.
FDA Clears New Blood Test for Alzheimer's Diagnosis
The FDA approved the Lumipulse G Plasma Ratio blood test for Alzheimer's, offering a less invasive and potentially cheaper diagnostic for patients over 55 with cognitive decline; the test achieved 92% accuracy in clinical trials detecting amyloid and tau proteins.
Progress
44% Bias Score
Showing 1 to 12 of 32 results